#USA #FutureCeuticals #Momence #NeuroRush #Aura Scientific

FutureCeuticals Files Lawsuit Against Aura Scientific

In a significant legal move, VDF FutureCeuticals, Inc. has embarked on a lawsuit against Aura Scientific, alleging that Aura's brain performance supplement, NeuroRush, violates multiple patents held by FutureCeuticals concerning coffee fruit technology. Specifically, the lawsuit details that NeuroRush, derived from the whole coffee fruit, infringes upon patents that encompass the formulation and utilization of coffee fruit to enhance cognitive abilities.

The core of the lawsuit highlights an issue of patent infringement, as FutureCeuticals has been a pioneer in developing the coffee fruit market, securing patents that cover the extraction processes of whole coffee fruit for several years. This includes patents that were affirmed through extensive human clinical studies that FutureCeuticals funded and published.

J. Randal Wexler, FutureCeuticals' Vice President and General Counsel, stated, "Aura Scientific's ingredient NeuroRush offers nothing new, simply 'piggybacking' on FutureCeuticals' renowned, robust science, and patented discoveries in the coffee fruit sector, with infringement as the clear consequence. Indeed, this is among the most open and willful infringements we've ever seen, harming not only us but our many licensees currently selling products containing our genuine ingredients, CognatiQ® and NeuroFactor®."

In its pursuit, FutureCeuticals not only seeks financial compensation but also demands a court ruling proclaiming the willful nature of the infringement, accompanied by a complete halt to the sales of the disputed ingredient. As Wexler emphasized, they have no option left but to rigorously protect their intellectual property rights while ensuring their customers' interests are safeguarded in whatever means necessary through legal channels.

Furthermore, FutureCeuticals' efforts to address the infringement are directed not only at stopping Aura Scientific but also at diminishing the broader market presence of NeuroRush, which has been recently incorporated into products from various dietary supplement brands. Wexler added a cautionary note to product manufacturers contemplating the inclusion of NeuroRush in their offerings. He encourages these businesses to assess their decisions in light of FutureCeuticals' extensive intellectual property rights.

"We take our obligations to protect our IP on behalf of ourselves and our customers very seriously," Wexler remarked, highlighting the company's commitment to defending its innovations.

For some context, VDF FutureCeuticals, Inc. is recognized as a leader in the research, development, and production of fruit, vegetable, and grain-based powders and extracts tailored for functional foods, beverages, and dietary supplements. Their mission revolves around unlocking the synergies found within plants, and they have established a reputation for pioneering nutritious plant-based ingredients. CognatiQ® and NeuroFactor® are two exclusive products offered by FutureCeuticals, stemming from their extensive research and innovation in the coffee fruit industry.

As this case unfolds, the implications of this lawsuit could resonate beyond the two companies involved, raising important questions about intellectual property rights in the health and wellness sector, particularly concerning the burgeoning coffee fruit extraction domain.